Envisagenics Funding & Investors
Envisagenics, Inc. develops health care software. The Company offers an artificial intelligence platform for drug discovery. Envisagenics provides RNA splicing analytics and artificial intelligence for therapeutic solutions. Envisagenics serves customers in the State of New York.
envisagenics.comTotal Amount Raised: $27,056,626
Envisagenics Funding Rounds
Series A
$19,181,626
Series A Investors
Dynamk CapitalMicrosoft VenturesThird Kind Venture CapitalRed Cell PartnersMadrona Venture GroupNew York VenturesSeed
$1,000,000
Seed Investors
Microsoft VenturesMadrona Venture GroupSeed
$2,400,000
Seed Investors
CosineDolby Family VenturesDynamk CapitalThird Kind Venture CapitalSVANew York StateGrant
$350,000
Grant Investors
The Thiel FoundationGrant
$2,000,000
Grant Investors
National Cancer Institute (NCI)Grant
$225,000
Grant Investors
National Institutes of Health (NIH)Grant
$50,000
Grant Investors
Accelerate Long IslandGrant
$1,500,000
Grant Investors
National Institutes of Health (NIH)Grant
$300,000
Grant Investors
National Cancer Institute (NCI)Pre Seed
$50,000
Pre Seed Investors
the Long Island Emerging technologies Fund (LIETF)
Funding info provided by Diffbot.